GSK

2,071

+0.68%↑

STJ

1,187.5

+1.89%↑

HIK

1,271

+1.6%↑

HILS

2,100

+0.72%↑

GSK

2,071

+0.68%↑

STJ

1,187.5

+1.89%↑

HIK

1,271

+1.6%↑

HILS

2,100

+0.72%↑

GSK

2,071

+0.68%↑

STJ

1,187.5

+1.89%↑

HIK

1,271

+1.6%↑

HILS

2,100

+0.72%↑

GSK

2,071

+0.68%↑

STJ

1,187.5

+1.89%↑

HIK

1,271

+1.6%↑

HILS

2,100

+0.72%↑

GSK

2,071

+0.68%↑

STJ

1,187.5

+1.89%↑

HIK

1,271

+1.6%↑

HILS

2,100

+0.72%↑

Strona główna・Stock List・Pets at Home Group Plc

Pets at Home Group Plc

Closed

SectorHealthcare

181.6 2.14

Buy Sell

Overview

Share price change

24h

Current

Min

176.6

Max

188.5

Key metrics
By Trading Economics
Income	26M
Sales	778M
P/E Sector Avg	11.088 57.05
EPS	0.056
Dividend yield	7.29
Profit margin	3.366
Employees	11,597
EBITDA	102M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+30.39% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	7.29% 2.52%

Market Stats
By TradingEconomics
Market Cap	833M
Previous open	179.46
Previous close	181.6

Pets at Home Group Plc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 mar 2026, 23:31 UTC

Hot Stocks

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Earnings

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 kwi 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Acquisitions, Mergers, Takeovers

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Market Talk

Major News Events

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Earnings

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Market Talk

Earnings

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Earnings

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Earnings

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Earnings

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Earnings

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Earnings

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Earnings

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Earnings

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Earnings

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Market Talk

Earnings

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Earnings

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Earnings

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Earnings

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Earnings

Nike CEO: Converse Remains Important to Portfolio

Peer Comparison

Price change

Pets at Home Group Plc Forecast

Price Target

By TipRanks

30.39% upside

12 Months Forecast

Average 230 GBX 30.39%

High 265 GBX

Low 195 GBX

Based on 2 Wall Street analysts offering 12 month price targets forPets at Home Group Plc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Pets at Home Group Plc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pets at Home Group Plc

Pets at Home Group Plc engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom. It operates through three segments: Retail, Vet Group, and Central. The company offers pet grooming services comprising a full dog groom, bath and blow dry, microchipping, and nail clipping; and pet insurance products, as well as other in-store services, including consultations with its trained pet nutritionists. Further, it offers general veterinary care; triage; and veterinary telehealth services. The company operates through pet care centers, stores, general practices, and grooming salons. It also provides products and services through online under the Pet at Home, Vets for Pets, Pet Grooming, Pets Foundation, and Pets VIP Club brands. Pets at Home Group Plc was founded in 1991 and is based in Handforth, the United Kingdom.